Abstract 68 Table 2 Median% LDL cholesterol (LDL-C) reduction

Time since starting PCSK9 inhibitorsMedian% LDL-C reductionRange
2 weeks (n=34*) 39.5% 6-71%
3 months (n=34*) 49.0% 4 - 78%
6 months (n=25) 47.0% 21- 76%
12 months (n=11) 50.0% 30-94%
  • *Two patients have high triglyceride levels therefore unable to obtain values for LDL-C. Total cholesterol (TC) reduction at 3 months ranged from 36%–66% in these two patients.